Medical device manufacturer Artivion disclosed that hackers accessed and stole company data during a cybersecurity breach on November 21, forcing the Georgia-based organization to take several systems offline.
The company, which specializes in implantable tissues for cardiac and vascular transplants, revealed the incident in a Securities and Exchange Commission filing on Monday. According to the document, the attack involved both "acquisition and encryption" of data, suggesting a possible ransomware attack, though the specific nature remains unconfirmed.
The cyber incident has disrupted Artivion's operations, particularly affecting order processing and shipping systems. However, the company, which reported $95.8 million in third-quarter revenue, stated that it does not anticipate the breach will materially impact its financial performance.
As of now, no ransomware group has publicly claimed responsibility for the attack on Artivion, formerly known as CryoLife. The company has not provided details about the volume or type of data compromised, nor specified which systems were impacted by the breach.
The incident follows a broader pattern of cyberattacks targeting healthcare and medical device companies, highlighting the sector's vulnerability to digital threats. Artivion continues to investigate the breach while working to restore affected systems and maintain business operations.
The company has not yet disclosed whether patient data was compromised or if the incident affects its ability to supply critical medical devices to healthcare providers. Further updates are expected as the investigation progresses.